Results 111 to 120 of about 1,960,988 (345)

Leukoreduced blood components: Advantages and strategies for its implementation in developing countries

Asian Journal of Transfusion Science, 2010
Removal of leucocytes from various blood products has been shown to minimize Febrile nonhemolytic transfusion reactions, HLA alloimmunization, platelet refractoriness in multitransfused patients and prevention of transmission of leukotropic viruses such ...
Sharma R, Marwaha Neelam
doaj  

Financial cost of whole blood and blood component disposals in a Brazilian coordinating blood center

Revista Gaúcha de Enfermagem
Objective: To describe the reasons for the disposal of blood in the coordinating blood center of the State of Paraná and to estimate the financial costs resulting from potentially avoidable discards.
Magali Zimmermann Covo, Elaine Drehmer de Almeida Cruz, Aline Batista Maurício, Josemar Batista, Liana Andrade Labres de Souza   +4 more
doaj   +2 more sources

Transfusion support in preterm neonates <1500 g and/or <32 weeks in a tertiary care center: A descriptive study

Asian Journal of Transfusion Science, 2018
Background: Lack of recent studies focusing on indications, pattern, and benefits of transfusions in low birth weight (B.Wt) and low gestational age (GA) preterm neonates prompted us to undertake this study.
R A Shanmugha Priya, R Krishnamoorthy, Vinod Kumar Panicker, Binu Ninan   +3 more
doaj   +1 more source

Towards an Innovative Sensor in Smart Capsule for Aerial Drones for Blood and Blood Component Delivery. [PDF]

Micromachines (Basel), 2022
Liu R, Pitruzzello G, Rosa M, Battisti A, Cerri C, Tortora G.   +5 more
europepmc   +1 more source

Circulatory and Renal Effects Following Transfusion of Human Blood and its Components to Dogs [PDF]

, 1956
Hadley L. Conn, John C. Wood, John C. Rose   +2 more
openalex   +1 more source

Detection rate for ESR1 mutations is higher in circulating‐tumor‐cell‐derived genomic DNA than in paired plasma cell‐free DNA samples as revealed by ddPCR

Molecular Oncology, EarlyView.
Analysis of ESR1 mutations in plasma cell‐free DNA (cfDNA) is highly important for the selection of treatment in patients with breast cancer. Using multiplex‐ddPCR and identical blood draws, we investigated whether circulating tumor cells (CTCs) and cfDNA provide similar or complementary information for ESR1 mutations.
Stavroula Smilkou, Aliki Ntzifa, Victoria Tserpeli, Ioanna Balgkouranidou, Alkistis Papatheodoridi, Evangelia Razis, Helena Linardou, Christos Papadimitriou, Amanda Psyrri, Flora Zagouri, Stylianos Kakolyris, Evi Lianidou   +11 more
wiley   +1 more source

Early Predictive Factors of Hypofibrinogenemia in Acute Trauma Patients

Journal of Emergencies, Trauma and Shock, 2018
Background: Uncontrolled hemorrhage still remains a major cause of trauma-associated mortality. The events resulting in acute traumatic coagulopathy, particularly hypofibrinogenemia, make control of bleeding difficult.
Shahram Paydar, Behnam Dalfardi, Zahra Shayan, Leila Shayan, Jalal Saem, Shahram Bolandparvaz   +5 more
doaj   +1 more source

Rotational ThromboElastometry-guided blood component administration versus standard of care in patients with Cirrhosis and coagulopathy undergoing Invasive ProcEdures (RECIPE): study protocol for a randomised controlled trial. [PDF]

Trials, 2023
Janko N, Majeed A, Kemp W, Hogan C, Nandurkar H, Roberts SK.   +5 more
europepmc   +1 more source

THE DETERMINATION OF THE LEVEL OF LEUKOCYTES IN THE BLOOD STREAM WITH INFLAMMATION. A THERMOSTABLE COMPONENT CONCERNED IN THE MECHANISM OF LEUKOCYTOSIS [PDF]

, 1949
Valy Menkin, Ruth Lewin, Louise Pirovane
openalex   +1 more source

Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer

Molecular Oncology, EarlyView.
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia, Anouk C. de Jong, Lisanne F. van Dessel, Vanja de Weerd, Corine Beaufort, Jean Helmijr, José Alberto Nakauma‐González, Job van Riet, Paul Hamberg, Daniel Vis, Michiel S. van der Heijden, Nick Beije, Martijn P. Lolkema, Teoman Deger, Saskia M. Wilting, Ronald de Wit, Maurice P. H. M. Jansen, John W. M. Martens   +17 more
wiley   +1 more source